Pharma · Private company
Kyowa Kirin, Inc.
Track this companyFree. Adds Kyowa Kirin, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials258 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- active vitamin DPhase 3 · X-Linked HypophosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
- burosumabPhase 3 · X-Linked HypophosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
- EN3267Phase 3 · PainClinicalTrials.gov · fetched Nov 12, 2026
- Oral Phosphate SupplementPhase 3 · X-Linked HypophosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
- Aflibercept InjectionPhase 2 · Neovascular Age-Related Macular Degeneration (nAMD)ClinicalTrials.gov · fetched Nov 12, 2026
- Aflibercept InjectionPhase 2 · Diabetic Macular Edema (DME)ClinicalTrials.gov · fetched Nov 12, 2026
- KHK4951Phase 2 · Diabetic Macular Edema (DME)ClinicalTrials.gov · fetched Nov 12, 2026
- KHK4951Phase 2 · Neovascular Age-Related Macular Degeneration (nAMD)ClinicalTrials.gov · fetched Nov 12, 2026
- KK2430Phase 2 · Hematologic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- KK8123Phase 2 · X-linked HypophosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
- KRN23Phase 2 · X-linked HypophosphatemiaClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- KK2223Phase 1 · T-cell NHL (PTCL or CTCL)ClinicalTrials.gov · fetched Nov 12, 2026
- KK2269Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- mogamulizumabPhase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin LymphomaPHASE1 · RECRUITING · started Sep 2, 2026ClinicalTrials.gov NCT07192471 · fetched Nov 12, 2026
- A Phase 1/2 Study of KK2430 in Participants With Hematologic NeoplasmsPHASE1_PHASE2 · RECRUITING · started Aug 1, 2026ClinicalTrials.gov NCT07629726 · fetched Nov 12, 2026
- A First-in-human Study of KK8123 in Adults With X-linked HypophosphatemiaPHASE1_PHASE2 · RECRUITING · started Oct 9, 2024ClinicalTrials.gov NCT06525636 · fetched Nov 12, 2026
- Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell LymphomaPHASE2 · RECRUITING · started Oct 9, 2024ClinicalTrials.gov NCT05996185 · fetched Nov 12, 2026
- Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular DegenerationPHASE2 · COMPLETED · started Jan 31, 2024ClinicalTrials.gov NCT06116890 · fetched Nov 12, 2026
- A Study of KK2269 in Adult Participants With Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 18, 2024ClinicalTrials.gov NCT06266299 · fetched Nov 12, 2026
- Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular EdemaPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 9, 2024ClinicalTrials.gov NCT06116916 · fetched Nov 12, 2026
- Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis FungoidesPHASE1 · SUSPENDED · started May 1, 2023ClinicalTrials.gov NCT05414500 · fetched Nov 12, 2026
- Istradefylline Effect Protocol on Parkinson's Disease TremorPHASE4 · COMPLETED · started Jan 20, 2023ClinicalTrials.gov NCT05885360 · fetched Nov 12, 2026
- Effect of Istradefylline Treatment on Behavioral Measures of Apathy in Parkinson's Disease.TERMINATED · started Jul 29, 2022ClinicalTrials.gov NCT05182151 · fetched Nov 12, 2026
- Istradefylline for Parkinson Disease With Cognitive ImpairmentPHASE2 · COMPLETED · started Jul 18, 2022ClinicalTrials.gov NCT05333549 · fetched Nov 12, 2026
- Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)PHASE3 · TERMINATED · started Aug 13, 2021ClinicalTrials.gov NCT04745832 · fetched Nov 12, 2026
- Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With MogamulizumabRECRUITING · started Sep 10, 2019ClinicalTrials.gov NCT04014374 · fetched Nov 12, 2026
- X-linked Hypophosphatemia Disease Monitoring ProgramACTIVE_NOT_RECRUITING · started Jul 16, 2018ClinicalTrials.gov NCT03651505 · fetched Nov 12, 2026
- Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant RecipientsPHASE2 · COMPLETED · started May 22, 2017ClinicalTrials.gov NCT02921789 · fetched Nov 12, 2026
- Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLHPHASE3 · COMPLETED · started Sep 8, 2016ClinicalTrials.gov NCT02915705 · fetched Nov 12, 2026
- Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)PHASE3 · COMPLETED · started Dec 23, 2015ClinicalTrials.gov NCT02537431 · fetched Nov 12, 2026
- Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)PHASE3 · COMPLETED · started Oct 22, 2015ClinicalTrials.gov NCT02526160 · fetched Nov 12, 2026
- Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung CancerPHASE1 · COMPLETED · started Jan 1, 2015ClinicalTrials.gov NCT02358473 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant RecipientsPHASE2 · COMPLETED · started Mar 5, 2013ClinicalTrials.gov NCT01780844 · fetched Nov 12, 2026
- An Extension Study of KRN23 in Adults With X-Linked HypophosphatemiaPHASE1_PHASE2 · COMPLETED · started Feb 1, 2012ClinicalTrials.gov NCT01571596 · fetched Nov 12, 2026
- A Repeated Study of KRN23 in Adults With X-Linked HypophosphatemiaPHASE1_PHASE2 · COMPLETED · started Apr 1, 2011ClinicalTrials.gov NCT01340482 · fetched Nov 12, 2026
- A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney TransplantationPHASE1 · COMPLETED · started Nov 17, 2010ClinicalTrials.gov NCT01279538 · fetched Nov 12, 2026
- A Study of KRN23 in X-linked HypophosphatemiaPHASE1 · COMPLETED · started Dec 1, 2008ClinicalTrials.gov NCT00830674 · fetched Nov 12, 2026
- Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer PatientsPHASE3 · COMPLETED · started Dec 1, 2005ClinicalTrials.gov NCT00263575 · fetched Nov 12, 2026